Canara HSBC Life Insurance Company Ltd's Q2 FY27 numbers came in mixed, with revenue of Rs. 2,581.25 Cr (+12.50% YoY) and PAT growth of +5.50% YoY. Here's a quick read of what worked, what to watch, and what management said.
| Results date | October 09, 2026 |
|---|---|
| Quarter | Q2 FY 2026-2027 |
| Revenue (Q2) | Rs. 2,581.25 Cr (+12.50% YoY) |
| PAT (Q2) | Rs. 43.05 Cr (+5.50% YoY) |
| EPS (Q2) | Rs. 0.45 (+4.70% YoY) |
| Market cap | Rs. 13,208.66 Cr |
| CMP | Rs. 139.22 |
Q2 FY27 gross premium grew 12.5% YoY to Rs.2,581 Cr with renewal premium up 15.6%, and H1 PAT rose 10.8% YoY to Rs.71.19 Cr, though normalized PAT was roughly flat after a Rs.2.86 Cr IL&FS write-back. The EoM ratio widened 180 bps YoY to 20.4% on the GST input-credit loss despite a 30 bps QoQ improvement, solvency declined to 180% from 198%, and persistency fell across 13- and 61-month cohorts. H2 outcomes hinge on ULIP MTM recovery, the expense-ratio trajectory, and the proposed Rs.287.50 Cr NCD issuance.
Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.